Healthcare & Life Sciences
Girihlet
Girihlet is a Healthcare & Life Sciences startup, most recent round Seed, 2 tracked investors.
activeseed
seed
Stage
2
Investors
About Girihlet
Girihlet is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Girihlet develops ImmuneScanner, a diagnostic tool to monitor autoimmune treatments and help patients and doctors select the best options. They collaborate with Mayo Clinic to study treatment effects on Ankylosing Spondylitis and create platforms for discovering strategies for complex immune diseases.
Explore Girihlet's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.